In-Stent Restenosis: Is the Future Bioresorbable?
- PMID: 39142759
- DOI: 10.1016/j.jcin.2024.06.018
In-Stent Restenosis: Is the Future Bioresorbable?
Keywords: In-stent restenosis; bioresorbable vascular scaffolds; long-term outcomes.
Conflict of interest statement
Funding Support and Author Disclosures Dr Claessen has received consultancy/speaker fees from Amgen, Boston Scientific, Philips, and Sanofi.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources